Bovine Lactoferrin Market is estimated to be 912.3 Million by 2029 with a CAGR of 5.3% during the forecasted period.

 


Bovine Lactoferrin Market accounted for US$ 572.6 Million in 2020 and is estimated to be US$ 912.3 Million by 2029 and is anticipated to register a CAGR of 5.3%.

The report "Global Bovine Lactoferrin Market, By Product (Spray-dried, and Freeze-dried), By Application (Infant Formula, Pharmaceuticals, Dietary Supplements, Food, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029”.

Key Highlights:

  • In April 2018, Ingredia announced the launch of a new product in the lactoferrin space. The company introduced PROFERRIN lactoferrin in the global market. This product was intended to be used in improving gut health and to exhibit anti-microbial and anti-inflammatory properties.
  • In March 2019, Hong Kong Jin Gang Trade Holding Limited announced that it has completed the acquisition of Westland Co-operative Dairy Company Limited with an aim to strengthen its market position in New Zealand.

Analyst View:

Increasing consumption of infant formula

An increasing number of working woman has been observed globally, which has lowered the overall breastfeeding rates. For instance, according to the data published by the World Health Organization (WHO), it is estimated that only 38.0% of all infant aged between 0 to 6 months are exclusively breastfed. Emerging countries like China, India and Japan have recorded higher growth in the ratio of female to male labor force, resulting working women shifting towards the infant formula feeding to the children, rather than breastfeeding. This has led to the higher demand in these countries.

Regulatory changes

During 2016-17, some countries in North America, Europe and Latin America allowed infant formula players to manufactures and market products with added lactoferrin. This has opened new regional markets for various manufacturers. For instance, in April 2017, Synlait Ltd. Received the FDA approval to export lactoferrin to the U.S., further to be used infant and toddler formula. Thus, these changes in regulation regarding to the use of protein as an added ingredient in infant formula are instrumental in rising demand for these products in global markets. However, the high cost of lactoferrin to limit the adoption in different product might be hampering the growth of the market.

Key Market Insights from the report:        

The global bovine lactoferrin market accounted for US$ 572.6 Million in 2020 and is estimated to be US$ 912.3 Million by 2029 and is anticipated to register a CAGR of 5.3%. The market report has been segmented on the basis of product, application and region.

  • Depending upon product, the freeze-dried segment is projected to grow at highest CAGR over the forecast period due to technical advantage of freeze drying techniques over spray dried such as high quality and purity of product coupled with comparatively higher iron-binding capacity.
  • Depending upon application, the infant formula segment is projected to grow at highest CAGR over the forecast period owing to rising awareness among common people regarding to health and immunity.
  • By region, North America dominated the market due to recent approval by the U.S. FDA for use of lactoferrin in infant formula. This is led to highest adoption rate as compared to the previous year.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4539

Competitive Landscape:

The prominent player operating in the global bovine lactoferrin market includes Fonterra Group, Bega Cheese, FrieslandCampina (DMV), Milei Gmbh, Glanbia Nutritionals, Westland Milk, Tatua, Synlait Milk, WBC, Murray Goulburn, and Ingredia Nutritional.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

Comments

Post a Comment

Popular posts from this blog

Humanized Liver Mice Model Market is estimated to be US$ 133.72 billion by 2030 with a CAGR of 5.30% during the forecast period

Image
Humanized Liver Mice Model Market   accounted for US$ 78.64 million in 2020 and is estimated to be US$ 133.72 million by 2030 and is anticipated to register a CAGR of 5.30%.  A lot of studies are underway to create novel humanized liver mouse models. Initially, liver mice models were created by implanting human liver cells or hepatic cancer cells into basic immune-deficient mice. The results, however, were inconsistent and unreliable. As a result, immune-deficient mice were developed, which spontaneously destroy the mice liver, allowing human liver cells to proliferate and replace it, resulting in stable humanized liver mice models. For example, a number of research projects are looking into using PPARalfa and AFC8-based mice models to develop humanized liver mice models. The report "Global Humanized Liver Mice Model Market, By Model (uPA-SCID, FRG KO Mice, TK-NOG Mice  and Other Models) By Application (Pharmacokinetics Studies, In-vivo Liver Toxicity Testing, Drug Metabolism Stud
Read more

Bipolar Disorder Market is estimated to be US$ 6.7 billion by 2030 with a CAGR of 2.3% during the forecast period

Image
Bipolar Disorder Market   accounted for US$ 5.3 billion in 2020 and is estimated to be US$ 6.7 billion by 2030 and is anticipated to register a CAGR of 2.3%. Bipolar disorder known as manic depression is a mental illness that brings low moods and severe high moods, thinking, changes in sleep and have periods in which they feel overly happy and energized and other side feel very sad, hopeless and sluggish. Bipolar disorder can cause severe disruption to a person’s life which can be treated with appropriate treatment and support. The report "   Global Bipolar Disorder Market, By Disorder (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder), By Drug Class (Mood Stabilizer, Anticonvulsant, Antipsychotic Drugs, Antidepressant Drugs, and Antianxiety Drugs), By Mechanism of Action (Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Beta Blockers, and Benzodiazepines), By Region (North
Read more

Monkeypox Disease Diagnostics Market - The abrupt global expansion of the monkeypox virus has increased the demand for monkeypox diagnostics.

Image
  The virus that causes smallpox and the Monkeypox both belong to the same family of viruses. Two outbreaks of a disease resembling the pox in groups of monkeys used for study led to the discovery of monkeypox in 1958. However, it has been observed in various parts of the world except Africa, where it is primarily found. It results in symptoms that resemble the flu, such as fever, chills, and a rash that might take weeks to go away. Even though instances of monkeypox are uncommon, they are growing in Africa and other areas where they have never before occurred. The fact that monkeypox is a rare disease may lead a healthcare provider to first rule out other rash infections, such measles or chickenpox. A tissue sample from an open sore is the first step in the medical professional's diagnosis of monkeypox (lesion). After that, send to a lab for PCR (Polymerase Chain Reaction). Additionally, blood is drawn to test for antibodies or the monkeypox virus. Currently, there is no licens
Read more